SlideShare a Scribd company logo
Importancia de los Modelos 
Matemáticos en Salud Pública 
César V. Munayco, MD, MSc, MPH 
Doctoral Student 
Department of Preventive Medicine and Biometrics 
Uniformed Services University of Health Sciences 
Bethesda, Maryland, USA. 
cesar.munayco@usuhs.edu
Usos de los modelos matemáticos en 
Salud Pública 
 Informar sobre políticas de Salud Pública 
 Simulación teórica de la patogénesis de una 
enfermedad 
 Estimar el impacto de intervenciones sanitarias para 
controlar enfermedades epidémicas como influenza, 
VIH, etc. 
 Determianr el impacto en la salud y estudios de costo-efectividad 
de intervenciones 
Basu S, Andrews J. Complexity in mathematical models of public health policies: a guide for 
consumers of models. PLoS Med. 2013 Oct;10(10):e1001540.
¿Qué es un modelo 
matemático? 
A mathematical model is an abstract 
model that uses mathematical language 
to describe the behaviour of a system. 
http://www.sciencedaily.com/articles/m/mathematical_model.htm
“All models are wrong, but 
some are useful.” 
George Box
“Models should be as simple 
as possible, but not simpler” 
Albert Einsten
Principios del modelamiento 
matemático 
Dym CL. Principles of mathematical modeling. 2nd ed. Amsterdam ; Boston: Elsevier Academic Press; 2004. 
xviii, 303 p. p.
¿Cómo se crea un modelo? 
Kallrath J. Modeling languages in mathematical optimization. Boston: Kluwer 
Academic Publishers; 2004. xxx, 407 p. p.
¿Cómo se crea un modelo? 
Kallrath J. Modeling languages in mathematical optimization. Boston: Kluwer 
Academic Publishers; 2004. xxx, 407 p. p.
Tipo de modelos matemáticos 
• Deterministic models: the same input will produce 
the same output. The only uncertainty in a 
deterministic model is generated by input variation. 
• Stochastic models: model involves some 
randomness and will not produce the same output 
given the same input.
Modelos determinísticos 
• Input factors: parameter values, initial conditions 
• The input factors are uncertain due to 
• natural variation 
• error in measurements 
• lack of current measurement techniques
Ejemplo SIR model 
Keeling MJ, Danon L. Mathematical modelling of infectious diseases. British medical bulletin. 
2009;92:33-42
Modelo Complejo 
Travis C. Porco, Sally M. Blower. Quantifying the Intrinsic Transmission Dynamics of 
Tuberculosis. Theoretical Population Biology 54, 117132 (1998)
Fiiting model to the data 
2 4 6 8 10 12 14 
0 50 100 150 200 250 300 
time, day 
Number of children in bed
Fiiting model to the data 
0 5 10 15 
0 50 100 150 200 250 300 
B 
time, day 
Numbers of 
Data 
fitted 
beta=2.4029, 
gamma=0.9093, 
delta=0.4123
Conceptos
Ejemplor de R0 
Gregory E. Glass. Measuring Disease Dynamics in Populations: Characterizing the Likelihood of Control. On 
line course. Johns Hopkins University
Relación entre la tasa de 
ataque y el R0 
Gregory E. Glass. Measuring Disease Dynamics in Populations: Characterizing the Likelihood of Control. On 
line course. Johns Hopkins University
Relación entre la inmunidad 
de grupo y el R0 
Gregory E. Glass. Measuring Disease Dynamics in Populations: Characterizing the Likelihood of Control. On 
line course. Johns Hopkins University
Inmundidad de grupo y R0
Inmunidad de grupo 
*4 doses 
† Modified from Epid Rev 1993;15: 265-302, Am J Prev Med 2001; 20 (4S): 88-153, 
MMWR 2000; 49 (SS-9); 27-38
Generaciones de una 
epidemia 
Notes On R0. James Holland Jones. Department of Anthropological Sciences. Stanford University
Análisis de sensibilidad 
• The objective of SA is to identify critical inputs 
(parameters and initial conditions) of a model and 
quantifying how input uncertainty impacts model 
outcome(s). 
• Local sensitivity analysis (LSA): examine change in 
output values based only on changes in one input 
factor. 
• Global sensitivity analysis (GSA): examine change 
in output values when all parameter values change.
Análisis de sensibilidad
Análisis de sensibilidad
Análisis de sensibilidad
Análisis de sensibilidad
Implicancias de dos 
parámetros diferentes 
Basu S, Andrews J. Complexity in mathematical models of public health policies: a guide for 
consumers of models. PLoS Med. 2013 Oct;10(10):e1001540.
Un ejemplo de sobreajuste 
de un modelo 
Basu S, Andrews J. Complexity in mathematical models of public health policies: a guide for 
consumers of models. PLoS Med. 2013 Oct;10(10):e1001540.
Un ejemplo de sobreajuste de un 
modelo 
Basu S, Andrews J. Complexity in mathematical models of public health policies: a guide for 
consumers of models. PLoS Med. 2013 Oct;10(10):e1001540.

More Related Content

Similar to Importancia delos modelos matemáticos en Salud Pública

Consumer and Connected Health: A New Day in Health and Healthcare?
Consumer and Connected Health: A New Day in Health and Healthcare?Consumer and Connected Health: A New Day in Health and Healthcare?
Consumer and Connected Health: A New Day in Health and Healthcare?
Bradford Hesse
 
Math modeling
Math modelingMath modeling
Math modeling
Cesar Munayco
 
GuoJian CV2014.6.26提交
GuoJian CV2014.6.26提交GuoJian CV2014.6.26提交
GuoJian CV2014.6.26提交JIan Guo
 
Effective strategies to monitor clinical risks using biostatistics - Pubrica.pdf
Effective strategies to monitor clinical risks using biostatistics - Pubrica.pdfEffective strategies to monitor clinical risks using biostatistics - Pubrica.pdf
Effective strategies to monitor clinical risks using biostatistics - Pubrica.pdf
Pubrica
 
statistics.ppt
statistics.pptstatistics.ppt
statistics.ppt
Shivraj Nile
 
INTRODUCTION TO BIO STATISTICS
INTRODUCTION TO BIO STATISTICS INTRODUCTION TO BIO STATISTICS
INTRODUCTION TO BIO STATISTICS
Meklelle university
 
Åpningssesjon: Infectious disease modelling
Åpningssesjon: Infectious disease modellingÅpningssesjon: Infectious disease modelling
Åpningssesjon: Infectious disease modelling
Nordisk statistikermøte 2013
 
Dr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptx
Dr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptxDr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptx
Dr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptx
PriyankaSharma89719
 
Running head Final Project Data Analysis1Final Project Data A.docx
Running head Final Project Data Analysis1Final Project Data A.docxRunning head Final Project Data Analysis1Final Project Data A.docx
Running head Final Project Data Analysis1Final Project Data A.docx
jeanettehully
 
Running head Final Project Data Analysis1Final Project Data A.docx
Running head Final Project Data Analysis1Final Project Data A.docxRunning head Final Project Data Analysis1Final Project Data A.docx
Running head Final Project Data Analysis1Final Project Data A.docx
wlynn1
 
Biostatistics and data analysis
Biostatistics and data analysisBiostatistics and data analysis
Biostatistics and data analysis
David Enoma
 
Statistics Introduction In Pharmacy
Statistics Introduction In PharmacyStatistics Introduction In Pharmacy
Statistics Introduction In Pharmacy
Pharmacy Universe
 
Towards Replicable and Genereralizable Genomic Prediction Models
Towards Replicable and Genereralizable Genomic Prediction ModelsTowards Replicable and Genereralizable Genomic Prediction Models
Towards Replicable and Genereralizable Genomic Prediction Models
Levi Waldron
 
The impact of different sources of heterogeneity on loss of accuracy from gen...
The impact of different sources of heterogeneity on loss of accuracy from gen...The impact of different sources of heterogeneity on loss of accuracy from gen...
The impact of different sources of heterogeneity on loss of accuracy from gen...
Levi Waldron
 
FORTUNE EFFIONG_COMPARATIVE ANALYSIS.pptx
FORTUNE EFFIONG_COMPARATIVE ANALYSIS.pptxFORTUNE EFFIONG_COMPARATIVE ANALYSIS.pptx
FORTUNE EFFIONG_COMPARATIVE ANALYSIS.pptx
TORASIF
 
statistics in pharmaceutical sciences
statistics in pharmaceutical sciencesstatistics in pharmaceutical sciences
statistics in pharmaceutical sciencesTechmasi
 
20140613 brn symposium
20140613 brn symposium20140613 brn symposium
20140613 brn symposium
jescarra
 
Implications for the Health Care System
Implications for the Health Care SystemImplications for the Health Care System
Implications for the Health Care System
brnbarcelona
 
Types of bias
Types of biasTypes of bias
Types of bias
DrDiplinaBarman
 
Projecting ‘time to event’ outcomes in technology assessment: an alternative ...
Projecting ‘time to event’ outcomes in technology assessment: an alternative ...Projecting ‘time to event’ outcomes in technology assessment: an alternative ...
Projecting ‘time to event’ outcomes in technology assessment: an alternative ...
cheweb1
 

Similar to Importancia delos modelos matemáticos en Salud Pública (20)

Consumer and Connected Health: A New Day in Health and Healthcare?
Consumer and Connected Health: A New Day in Health and Healthcare?Consumer and Connected Health: A New Day in Health and Healthcare?
Consumer and Connected Health: A New Day in Health and Healthcare?
 
Math modeling
Math modelingMath modeling
Math modeling
 
GuoJian CV2014.6.26提交
GuoJian CV2014.6.26提交GuoJian CV2014.6.26提交
GuoJian CV2014.6.26提交
 
Effective strategies to monitor clinical risks using biostatistics - Pubrica.pdf
Effective strategies to monitor clinical risks using biostatistics - Pubrica.pdfEffective strategies to monitor clinical risks using biostatistics - Pubrica.pdf
Effective strategies to monitor clinical risks using biostatistics - Pubrica.pdf
 
statistics.ppt
statistics.pptstatistics.ppt
statistics.ppt
 
INTRODUCTION TO BIO STATISTICS
INTRODUCTION TO BIO STATISTICS INTRODUCTION TO BIO STATISTICS
INTRODUCTION TO BIO STATISTICS
 
Åpningssesjon: Infectious disease modelling
Åpningssesjon: Infectious disease modellingÅpningssesjon: Infectious disease modelling
Åpningssesjon: Infectious disease modelling
 
Dr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptx
Dr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptxDr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptx
Dr. RM Pandey -Importance of Biostatistics in Biomedical Research.pptx
 
Running head Final Project Data Analysis1Final Project Data A.docx
Running head Final Project Data Analysis1Final Project Data A.docxRunning head Final Project Data Analysis1Final Project Data A.docx
Running head Final Project Data Analysis1Final Project Data A.docx
 
Running head Final Project Data Analysis1Final Project Data A.docx
Running head Final Project Data Analysis1Final Project Data A.docxRunning head Final Project Data Analysis1Final Project Data A.docx
Running head Final Project Data Analysis1Final Project Data A.docx
 
Biostatistics and data analysis
Biostatistics and data analysisBiostatistics and data analysis
Biostatistics and data analysis
 
Statistics Introduction In Pharmacy
Statistics Introduction In PharmacyStatistics Introduction In Pharmacy
Statistics Introduction In Pharmacy
 
Towards Replicable and Genereralizable Genomic Prediction Models
Towards Replicable and Genereralizable Genomic Prediction ModelsTowards Replicable and Genereralizable Genomic Prediction Models
Towards Replicable and Genereralizable Genomic Prediction Models
 
The impact of different sources of heterogeneity on loss of accuracy from gen...
The impact of different sources of heterogeneity on loss of accuracy from gen...The impact of different sources of heterogeneity on loss of accuracy from gen...
The impact of different sources of heterogeneity on loss of accuracy from gen...
 
FORTUNE EFFIONG_COMPARATIVE ANALYSIS.pptx
FORTUNE EFFIONG_COMPARATIVE ANALYSIS.pptxFORTUNE EFFIONG_COMPARATIVE ANALYSIS.pptx
FORTUNE EFFIONG_COMPARATIVE ANALYSIS.pptx
 
statistics in pharmaceutical sciences
statistics in pharmaceutical sciencesstatistics in pharmaceutical sciences
statistics in pharmaceutical sciences
 
20140613 brn symposium
20140613 brn symposium20140613 brn symposium
20140613 brn symposium
 
Implications for the Health Care System
Implications for the Health Care SystemImplications for the Health Care System
Implications for the Health Care System
 
Types of bias
Types of biasTypes of bias
Types of bias
 
Projecting ‘time to event’ outcomes in technology assessment: an alternative ...
Projecting ‘time to event’ outcomes in technology assessment: an alternative ...Projecting ‘time to event’ outcomes in technology assessment: an alternative ...
Projecting ‘time to event’ outcomes in technology assessment: an alternative ...
 

Recently uploaded

ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
Sai Sailesh Kumar Goothy
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Vision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of opticsVision-1.pptx, Eye structure, basics of optics
Vision-1.pptx, Eye structure, basics of optics
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 

Importancia delos modelos matemáticos en Salud Pública

  • 1. Importancia de los Modelos Matemáticos en Salud Pública César V. Munayco, MD, MSc, MPH Doctoral Student Department of Preventive Medicine and Biometrics Uniformed Services University of Health Sciences Bethesda, Maryland, USA. cesar.munayco@usuhs.edu
  • 2. Usos de los modelos matemáticos en Salud Pública  Informar sobre políticas de Salud Pública  Simulación teórica de la patogénesis de una enfermedad  Estimar el impacto de intervenciones sanitarias para controlar enfermedades epidémicas como influenza, VIH, etc.  Determianr el impacto en la salud y estudios de costo-efectividad de intervenciones Basu S, Andrews J. Complexity in mathematical models of public health policies: a guide for consumers of models. PLoS Med. 2013 Oct;10(10):e1001540.
  • 3. ¿Qué es un modelo matemático? A mathematical model is an abstract model that uses mathematical language to describe the behaviour of a system. http://www.sciencedaily.com/articles/m/mathematical_model.htm
  • 4. “All models are wrong, but some are useful.” George Box
  • 5. “Models should be as simple as possible, but not simpler” Albert Einsten
  • 6. Principios del modelamiento matemático Dym CL. Principles of mathematical modeling. 2nd ed. Amsterdam ; Boston: Elsevier Academic Press; 2004. xviii, 303 p. p.
  • 7. ¿Cómo se crea un modelo? Kallrath J. Modeling languages in mathematical optimization. Boston: Kluwer Academic Publishers; 2004. xxx, 407 p. p.
  • 8. ¿Cómo se crea un modelo? Kallrath J. Modeling languages in mathematical optimization. Boston: Kluwer Academic Publishers; 2004. xxx, 407 p. p.
  • 9. Tipo de modelos matemáticos • Deterministic models: the same input will produce the same output. The only uncertainty in a deterministic model is generated by input variation. • Stochastic models: model involves some randomness and will not produce the same output given the same input.
  • 10. Modelos determinísticos • Input factors: parameter values, initial conditions • The input factors are uncertain due to • natural variation • error in measurements • lack of current measurement techniques
  • 11. Ejemplo SIR model Keeling MJ, Danon L. Mathematical modelling of infectious diseases. British medical bulletin. 2009;92:33-42
  • 12. Modelo Complejo Travis C. Porco, Sally M. Blower. Quantifying the Intrinsic Transmission Dynamics of Tuberculosis. Theoretical Population Biology 54, 117132 (1998)
  • 13. Fiiting model to the data 2 4 6 8 10 12 14 0 50 100 150 200 250 300 time, day Number of children in bed
  • 14. Fiiting model to the data 0 5 10 15 0 50 100 150 200 250 300 B time, day Numbers of Data fitted beta=2.4029, gamma=0.9093, delta=0.4123
  • 16. Ejemplor de R0 Gregory E. Glass. Measuring Disease Dynamics in Populations: Characterizing the Likelihood of Control. On line course. Johns Hopkins University
  • 17. Relación entre la tasa de ataque y el R0 Gregory E. Glass. Measuring Disease Dynamics in Populations: Characterizing the Likelihood of Control. On line course. Johns Hopkins University
  • 18. Relación entre la inmunidad de grupo y el R0 Gregory E. Glass. Measuring Disease Dynamics in Populations: Characterizing the Likelihood of Control. On line course. Johns Hopkins University
  • 20. Inmunidad de grupo *4 doses † Modified from Epid Rev 1993;15: 265-302, Am J Prev Med 2001; 20 (4S): 88-153, MMWR 2000; 49 (SS-9); 27-38
  • 21. Generaciones de una epidemia Notes On R0. James Holland Jones. Department of Anthropological Sciences. Stanford University
  • 22. Análisis de sensibilidad • The objective of SA is to identify critical inputs (parameters and initial conditions) of a model and quantifying how input uncertainty impacts model outcome(s). • Local sensitivity analysis (LSA): examine change in output values based only on changes in one input factor. • Global sensitivity analysis (GSA): examine change in output values when all parameter values change.
  • 27. Implicancias de dos parámetros diferentes Basu S, Andrews J. Complexity in mathematical models of public health policies: a guide for consumers of models. PLoS Med. 2013 Oct;10(10):e1001540.
  • 28. Un ejemplo de sobreajuste de un modelo Basu S, Andrews J. Complexity in mathematical models of public health policies: a guide for consumers of models. PLoS Med. 2013 Oct;10(10):e1001540.
  • 29. Un ejemplo de sobreajuste de un modelo Basu S, Andrews J. Complexity in mathematical models of public health policies: a guide for consumers of models. PLoS Med. 2013 Oct;10(10):e1001540.

Editor's Notes

  1. Infectious disease models provide a mathematical representation of the dynamic transmission cycle, involving interactions between infected and susceptible hosts that are generally expressed as a set of coupled ordinary differential equations (ODEs)
  2. George Edward Pelham Box FRS was a english statistician, who worked in the areas of quality control, time-series analysis, design of experiments, and Bayesian inference.
  3. A parsimonious approach must be followed. Otherwise, if every mechanism and interaction is included, the resulting mathematical model will be comprised of a large number of variables, parameters, and constraints, most of them uncertain because they are difficult to measure experimentally, or are even completely unknown in many cases Parsimonious principle: It states that among competing hypotheses, the one with the fewest assumptions should be selected. Other, more complicated solutions may ultimately prove correct, but—in the absence of certainty—the fewer assumptions that are made, the better.
  4. Both a 1-month duration of acute infection with six secondary infections per month (top graph) and a 3-month duration of acute infection with two secondary infections per month (bottom graph) produce the same result of six infections per person during the acute infectious period. But the implications of the two different parameter sets are very different, as early treatment (red dashed line) would be effective in preventing secondary infections only in the latter case. Suppose we have a model of HIV with just two parameters: the number of infections per month during acute HIV infection and the duration of elevated transmission risk during acute infection. But we only have one data point that tells us that a typical infected person causes six secondary infections during their acute infectious Period.